Evidence map›Paper›PMID 30455397›Full record

ArticleBioscience reports2018

Preconditioning lessens high fat induced metabolic syndrome along with markers of increased metabolic capacity in muscle and adipose tissue.

Songpei Li, Xiu Zhou, Eunjung Jo, Ali Mahzari, Sherouk Fouda, Dongli Li, Kun Zhang, Ji-Ming Ye

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Songpei LiSchool of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Xiu ZhouSchool of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Eunjung JoSchool of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Ali MahzariSchool of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Sherouk FoudaSchool of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Dongli LiSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Kun ZhangSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Ji-Ming YeSchool of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia jiming.ye@rmit.edu.au.ORCID 0000-0003-3983-0098
RMIT University · AUWuyi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postnatal overconsumption of fat is believed to increase the susceptibility to metabolic disease in the later life. Here we examined whether prior exposure to high fat (HF) in the adulthood may also accelerate the development of metabolic disorders in mice. Adult mice (12 weeks) were pre-exposed to two episodes of an HF diet each for 2 weeks followed by 2 weeks of washout with a low-fat diet. The mice were then fed the same HF diet for 6 weeks. Unexpectedly, prior exposures to HF diet significantly alleviated body weight gain, visceral adiposity and glucose/insulin intolerance during the period of last HF feeding. These protective effects were evident without changing calorie intake and were specific for HF, but not high fructose (HFru) diet. Following the HF prior exposures was increases in plasma fibroblast growth factor 21 (FGF21), the expressions of phospho-AMP-activated protein kinase (pAMPK), mitochondrial complex II and the expression of uncoupling protein (UCP) 3 in muscle and UCP1 and Sirtuin 1 (SIRT1) in adipose tissue. However, in the liver there was no significant change in pAMPK, SIRT1 expression or the capacity of glucose production. These findings indicated that, instead of exacerbating metabolic conditions, prior exposures to HF diet lead to the preconditioning against subsequent overload of HF, possibly involving FGF21-associated enhancement of markers for metabolic capacity in muscle and adipose tissue. This paradoxical phenomenon may offer a unique paradigm to identify factors and explore dietary ingredients with beneficial effects for the control of the metabolic syndrome in humans.

Indexed as

Adipose TissueAdiposityAnimalsDiet, High-FatFibroblast Growth FactorsGlucoseGlucose Tolerance TestInsulinMaleMetabolic SyndromeMice, Inbred C57BLMuscle, SkeletalWeight Gainfibroblast growth factor 21Fibroblast Growth FactorsGlucoseInsulinFGF21high fat dietmetabolic disordersobesitypreconditioning

Identifiers

PMID30455397
PMCPMC6294636
OpenAlexW2901217051

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.